Home/Research
Research

The work on the page.

Peer-reviewed publications from Dr. Keerthy Sunder and collaborators — spanning personalized rTMS, EEG-guided neuromodulation, PTSD and TBI, reward deficiency, and the neurobiology of recovery. Every entry links directly to PubMed or the journal.

A running ledger of Dr. Sunder's peer-reviewed publications — personalized rTMS, EEG-guided neuromodulation, PTSD, TBI, autism spectrum, and reward-deficiency research. Every entry opens on PubMed or the journal's own page.
24+
Peer-reviewed publications
2026
Most recent
Full PubMed bibliography →
Latest publication · February 2026

Spectral EEG-guided adaptive neuromodulation for age-related cognitive changes.

A longitudinal case report exploring functional, affective, sleep, and quality-of-life outcomes following EEG-spectra-guided PrTMS in a 73-year-old patient experiencing age-related cognitive changes — demonstrating substantial improvements in perceived cognitive function, mood, anxiety, and sleep.

Mahajan Y, Sunder K, et al. (2026). Spectral EEG-Guided Adaptive Neuromodulation for Age-Related Cognitive Changes: A Longitudinal Case Report. Frontiers in Medical Case Reports. doi: 10.47746/FMCR.2026.7103
Read the paper View on PubMed
Frontiers in Medical Case Reports — 2026
2026
Peer-reviewed

rTMS for recurrent MDD and GAD comorbid with atrial fibrillation: a case report.

Reddy V, Frutkin N, Singh A, Sunder K, et al. (Feb 2026). Frontiers in Psychiatry. DOI: 10.3389/fpsyt.2026.1719274
55% reduction in PHQ-9 · 22.2% reduction in GAD-7 · first study demonstrating safety of figure-8 coil rTMS at 10 Hz in MDD comorbid with AF.
Read
2026
Peer-reviewed

Maintenance transcranial photobiomodulation following an acute rTMS course for recurrent MDD and GAD: a case series.

Odron M, Reddy V, Mohankumar K, Sunder K, et al. (Jan 2026). Acta Scientific Neurology. DOI: 10.31080/ASNE.2026.09.0893
Feasibility of tPBM as maintenance after acute rTMS · clinical response sustained ~6 months in all three patients.
Read
2025
Peer-reviewed

rTMS for recurrent MDD and GAD comorbid with thalamic pain syndrome: a case report.

Reddy V, McDaniel H, Katta A, Sunder K, et al. (Nov 2025). EC Clinical and Medical Case Reports. DOI: 10.31080/ECMCR.2025.08.1033
95.5% reduction in PHQ-9 · 88.2% reduction in GAD-7 · notable improvement in neuropathic pain and quality of life.
Read
2025
Peer-reviewed

rTMS for recurrent MDD and GAD comorbid with heart failure, renal disease, type 2 diabetes, and HIV: a case report.

Odron M, Mohankumar K, Mahajan S, Sunder K, et al. (Jun 2025). EC Clinical and Medical Case Reports. DOI: 10.31080/ECMCR.2025.08.0857
>50% symptom reduction by week 5 · >80% improvement from week 6 onward, despite multi-systemic comorbidities.
Read
2025
Peer-reviewed

Personalized rTMS in pediatric patients with autism: a case series exploring therapeutic outcomes.

Mohankumar K, Sanjay L, Kumar SK, Sunder K, et al. (Mar 2025). EC Neurology. DOI: 10.31080/ECNE.2025.17.0170
Average 7.5-point reduction in CARS scores · 9-point reduction in ADHD symptoms (NICHQ Vanderbilt) over six weeks.
Read
2025
Peer-reviewed

PrTMS coupled with tPBM for co-occurring traumatic brain injury and PTSD.

Mahajan S, Bodahanapati A, Katta A, Sunder K, et al. (Feb 2025). Acta Scientific Neurology. DOI: 10.31080/ASNE.2025.08.0809
64.29% reduction in GAD-7 · 50% decrease in PHQ-9 · 74.07% reduction in NSI · 68.63% decrease in PCL-5.
Read
2025
Peer-reviewed

EEG-spectra-guided personalized rTMS in PTSD with co-occurring psychiatric disorders: a case series.

Mohankumar K, Karthikeya S, Mahajan S, Sunder K, et al. (Jan 2025). Acta Scientific Neurology. PMID: 39581107
PCL-5 average reduction of 20.5 points by midpoint · GAD-7 down 7 points · PHQ-9 down 8.5 points.
Read
2024
Peer-reviewed

Pilot study of personalized TMS with spectral EEG analyses for assessing and treating persons with autism.

Makale MT, Nybo C, Blum K, Dennen CA, Elman I, Murphy KT, Sunder K. (Aug 2024). Journal of Personalized Medicine. DOI: 10.3390/jpm14080857
Open-label pilot in 123 ABA-treated ASC persons · 44% of subjects had ASC scale scores reduced below diagnostic cutoffs.
Read
2024
Peer-reviewed

Dopamine dysregulation in reward and autism spectrum disorder.

Blum K, Bowirrat A, Sunder K, Thanos PK, et al. (Jul 2024). Brain Sciences. DOI: 10.3390/brainsci14070733
Comprehensive review · multi-level framework organizing ASD pathogenesis from genetic changes through neurocognitive manifestations.
Read
2023
Peer-reviewed

Addiction and reward deficiency syndrome (RDS): a gene-based therapeutic strategy?

Bowirrat A, Sunder K, et al. (Nov 2023). Addiction Medicine. PMID: 38050640
Gene-based therapeutic strategies for RDS and its implications in addiction treatment.
Read
2023
Peer-reviewed

Genetic Addiction Risk Score (GARS): clinical utility in reward deficiency syndrome.

Blum K, Sunder K, et al. (Sep 2023). Medical Archives.
Precision-medicine approach to diagnosing and treating RDS.
Read
2023
Peer-reviewed

Preliminary observations of PrTMS guided by EEG spectra for concussion.

Makale MT, Nybo C, Keifer J, Blum K, Dennen CA, Baron D, Sunder K, et al. (Aug 2023). Brain Sciences. PMID: 37626535
Pilot clinical data on PrTMS for concussion · restoration of alpha oscillatory synchrony · improved cognitive function.
Read
2023
Peer-reviewed

Personalized rTMS for PTSD in military combat veterans.

Makale MT, Nybo C, Keifer J, Blum K, Baron D, Sunder K, et al. (Jul 2023). Heliyon. DOI: 10.1016/j.heliyon.2023.e18943
Statistically significant improvements in PTSD, anxiety, and depression through spectral EEG-guided personalized neuromodulation.
Read
2023
Peer-reviewed

Impact of neuro-psychiatric disorders on the global economy.

Blum K, Sunder K, et al. (Mar 2023). Psychology. PMID: 37560184
Critical analysis of the economic burden of neuro-psychiatric disorders · cost-effectiveness of early intervention.
Read
2023
Peer-reviewed

Exploratory analysis of dopamine D2 agonist therapy.

Blum K, Sunder K, Badgaiyan RD. (Feb 2023). Pharmacology. PMID: 37361347
Potential of D2 agonist therapy in psychiatric conditions · mechanism of action and clinical response.
Read
Full bibliography on PubMed →

Collaborating on research?

The Foundation welcomes correspondence from clinicians, researchers, and graduate students working in adjacent territory.

Write to us